Does an insurance appraisal match the ring’s resale value?

Daniel came in last spring with an appraisal for $11,400 on a ring he'd bought two years earlier. He wanted to sell it. The best cash offer he got, after three dealers looked at it, was $2,100. That gap isn't a mistake. An insurance appraisal doesn't match a ring's resale value, and the gap is usually bigger than clients expect.

An appraisal written for insurance is a replacement-cost document. It tells your insurer what a comparable ring would cost to buy new, at full retail, today, from a proper jeweler, and that number includes the jeweler's markup, the setting's labor, the stone's retail margin, and often a cushion because the appraiser doesn't want you underinsured if prices move next year. Many appraisals I see come in 20 to 40 percent above what the client actually paid. That's not fraud. It's a different job.

Why resale is so much lower

The secondary market doesn't pay retail. A dealer buying a pre-owned engagement ring has to clean it, maybe re-tip the prongs, maybe send the stone to GIA for a fresh report if the paperwork is weak, and then hold it until someone buys it. That buyer will expect a discount for purchasing secondhand. The dealer needs margin. So you're not selling at replacement cost. You're selling at wholesale minus labor and risk.

The setting itself is usually worth scrap. A $2,400 platinum head and shank might bring $180 as metal. Melee diamonds around a center stone? Pennies. The labor you paid for doesn't transfer. The design doesn't transfer. What's left is the center stone, and your modern round brilliant in a common size is not rare.

I bought a 1.04 carat F/VS1 round, GIA triple excellent, from a client last year for $2,300. It had retailed for $6,800 eighteen months earlier. That's not me being cheap. That's what the stone would bring if I walked it down to 47th Street that afternoon, and I still had to hold it for seven months before it sold.

Lab-grown and the resale cliff

If the stone is lab-grown, the resale number is uglier. I've stopped writing appraisals that suggest lab-grown diamonds have meaningful resale value, because they don't. The price floor keeps falling. A lab-grown stone someone paid $4,000 for in 2022 might sell for $300 cash today, if a dealer will take it at all. Many won't. I tell clients buying lab-grown to think of it like a new car: you're buying the object, not an asset.

Natural stones do hold something, but nowhere near appraisal. Old European cuts and antique cushions do better because they're scarce and people like me actively look for them. A good 1.2 carat old European with nice facet pattern might bring 50 or 60 percent of what a retail equivalent would cost, sometimes more if the stone is exceptional and the right buyer sees it. Modern round brilliants are the opposite. There are thousands of them, and the market is efficient in a way that kills resale.

What the appraisal is actually good for

None of this means the appraisal is useless. It's for insurance. If the ring is lost or stolen, the insurer needs a defensible replacement number to make you whole with a comparable new piece. A good appraisal keeps you from fighting after a loss. But it should be accurate, not aspirational. Inflated appraisals raise your premium without raising what the insurer will actually pay if the loss is legitimately replaced at market.

If you want a resale number, get cash offers from at least three buyers. A dealer, a pawnshop, and maybe an auction specialist if the piece has age or provenance. That's the real number. The appraisal will almost always be higher, sometimes three times higher, and that's not because someone is cheating you. They're measuring two different things.

Daniel kept the ring. Once he understood the numbers, he realized selling it made no sense, and he liked it anyway. That's the part appraisals never tell you: a ring you love is worth more on your hand than in a dealer's case.